A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
批准号:
7605184
负责人:
THOMAS C MERIGAN
金额:
$0.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
A5132是一项探索性、开放标签、随机试验,旨在评估IL-2增强HIV特异性免疫反应的能力,并影响有效的抗逆转录病毒治疗(ART)中断后病毒学反弹的速度。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
A5132 is an exploratory, open-label, randomized trial to evaluate the ability of IL-2 to enhance HIV-specific immune responses and influence the rate of virologic rebound following potent antiretroviral therapy (ART) interruptions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7605200
-
项目类别:
-
资助金额:$4.74万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7605165
-
项目类别:
-
资助金额:$2.09万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7375261
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7375239
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7375194
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7375233
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
ACTG 5001 ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED
-
批准号:7202022
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
VIROLOGIC STUDIES IN COMPARTMENTAL SAMPLES FROM HIV-INFECTED SUBJECTS
-
批准号:7202038
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV INFECTION
-
批准号:7202039
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
RIBAVIRIN ON ZIDOVUDINE OR STAVUDINE TRIPHOSPHATE FORMATION A5092S IN AIDS
-
批准号:7202053
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TRIAL OF VALGANCICLOVIR ACTG 5030 AIDS STUDY
-
批准号:7202032
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TREATMENT OF ELEVATED NON-HDL CHOLESTEROL AND ELEVATED TRIGLYCERIDES IN HIV
-
批准号:7202065
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PULSE THERAPY ON THE CHARACTERISTICS OF TREATMENT INTERRUPTIONS AIDS
-
批准号:7202042
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
GENE CONSTRUCT IN THE TREATMENT OF PATIENTS WITH HIV-1 INFECTION
-
批准号:7202052
-
项目类别:
-
资助金额:$9.08万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7202023
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7202080
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7202085
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7202114
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH FAILURE OF PREVIOUS PROTEASE INHIBITOR-BASED REGIMENS
-
批准号:7202075
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
A5132 AN EXPLORATORY, OPEN-LABEL, RANDOMIZED TRIAL
-
批准号:6980971
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2003
-
负责人:THOMAS C MERIGAN
-
依托单位:
海外基金